United Kingdom - English - myHealthbox

gp-pharm, s.a - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 22.5mg - hormones and related agents. gonadotropin-releasing hormones analogues - it is indicated for palliative treatment of hormone dependent advanced prostate cancer.

Canada - English - Health Canada

abbvie corporation - leuprolide acetate - solution - 5mg - leuprolide acetate 5mg - gonadotropins

Canada - English - Health Canada

abbvie corporation - leuprolide acetate - powder for suspension, sustained-release - 7.5mg - leuprolide acetate 7.5mg - gonadotropins

Canada - English - Health Canada

abbvie corporation - leuprolide acetate - powder for suspension, sustained-release - 3.75mg - leuprolide acetate 3.75mg - gonadotropins

Canada - English - Health Canada

abbvie corporation - leuprolide acetate - powder for suspension, sustained-release - 22.5mg - leuprolide acetate 22.5mg - gonadotropins

Canada - English - Health Canada

abbvie corporation - leuprolide acetate - powder for suspension, sustained-release - 30mg - leuprolide acetate 30mg - gonadotropins

Canada - English - Health Canada

abbvie corporation - leuprolide acetate - powder for suspension, sustained-release - 11.25mg - leuprolide acetate 11.25mg - gonadotropins

Malta - English - Medicines Authority

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - leuprorelin acetate - implant - leuprorelin acetate 5 mg - endocrine therapy

Singapore - English - HSA (Health Sciences Authority)

sandoz singapore pte. ltd. - leuprorelin acetate eqv. leuprorelin - implant - leuprorelin acetate eqv. leuprorelin 3.6 mg

Singapore - English - HSA (Health Sciences Authority)

sandoz singapore pte. ltd. - leuprorelin acetate eqv. leuprorelin - implant - leuprorelin acetate eqv. leuprorelin 5.0 mg